-
Recent Posts
- Dementia-Friendly Communities Provision, Viewed as a Social Determinant of Health (JGCR / NHS England / WHO)
- International Perspectives on the Possible Impact of the COVID-19 Pandemic and Lockdown on Abuse of the Elderly (JGCR / American Journal of Geriatric Psychiatry / JAGS)
- Updates Relating to the Lancet Commission on Dementia Prevention, Intervention, and Care (Lancet / Alzheimer’s Research and Therapy / Alzheimer’s and Dementia)
- A Brief Review of How the COVID-19 Pandemic Relates to Elderly Care and Research (JGCR)
- Some Speculated / Potential Benefits of COVID-19 (JGCR / BBC Radio 4’s Rethink / BGS)
Archives
- September 2020
- August 2020
- June 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Tag Archives: Potentially Inappropriate Prescribing (PIP)
National Audit of Dementia Care in General Hospitals: Spotlight Audit on Psychotropic Medication (HQIP / RCP)
Summary The Healthcare Quality Improvement Partnership (HQIP) and Royal College of Psychiatrists have published a spotlight audit on the use of psychotropic medicines in the care of people with dementia in general hospitals in England and Wales. Psychotropic medication may … Continue reading
Posted in Acute Hospitals, Antipsychotics, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Local Interest, Management of Condition, Mental Health, Models of Dementia Care, National, NHS, Person-Centred Care, Pharmacological Treatments, Quick Insights, Royal College of Psychiatrists, Standards, Statistics, UK, Universal Interest
Tagged Acute Care, Acute Hospital Care, Alternatives to Antipsychotic Drugs, Alternatives to Antipsychotic Medication, Anticonvulsants: as Mood Stabilisers, Antidepressants, Avoidable Harm, Avoidable Harm: Psychotropic Dosages and Drug Interactions, Behavioral and Psychological Symptoms of Dementia (BPSD), Behavioural and Psychological Symptoms of Dementia (BPSD), Dementia Care in Acute General Hospitals, Dementia Care in Acute Settings, Dementia Care in General Hospitals, Dementia Care in the Acute Hospital, Dementia Friendly Acute Hospitals, Dementia in General Hospital Inpatients, Dementia Medications, Discharge Medicines Review Service, Drugs for BPSD, Falls Prevention, Healthcare Quality Improvement Partnership (HQIP), Hypnotics and Anxiolytics, Medicines Optimisation, Medicines Reconciliation, National Audit of Dementia (Care in General Hospitals), National Audit of Dementia (NAD), National Audit of Dementia Care in General Hospitals: Spotlight Audit on Psychotropic Medication (2020), National Audit of Dementia Care in Hospitals, National Audit of Dementia: Spotlight Report on Psychotropic Medication, National Falls Prevention CQUIN, Patient Discharge, Patient Discharge Summaries, Patient Notes, Patient Records, Patient Safety, Patterns of Psychotropic Prescriptions, Potential Harms of Antipsychotic Use, Potentially Inappropriate Medications (PIMs), Potentially Inappropriate Medicine Combinations, Potentially Inappropriate Prescribing, Potentially Inappropriate Prescribing (PIP), Potentially Inappropriate Prescribing in Older People With Dementia, Prescribing of Antipsychotic Drugs For People With Dementia, Prescription of Psychotropic Drugs, Prescription of Psychotropic Medication Initiated in Hospitals for BPSD, Prescriptions Reviewed on Discharge, Prevalence of Potentially Inappropriate Prescribing of Antipsychotic Drugs, Psychological Symptoms of Dementia (BPSD), Psychotropic Drug Cessation, Psychotropic Drug Use (Antipsychotics Antidepressants Hypnotics Anxiolytics Anticonvulsants Antidementia Drugs), Psychotropic Drugs, Psychotropic Medication, Psychotropic Prescribing, QI: Quality Improvement, Quality Improvement, Reducing Antipsychotic Prescriptions in Dementia, Reducing Avoidable Harm, Reducing Inappropriate Polypharmacy, Reducing Inappropriate Use of Antipsychotics in Dementia, Regular and PRN Prescriptions, Royal College of Psychiatrists, Royal College of Psychiatrists (RCP), Royal College of Psychiatrists Centre for Quality Improvement (CCQI), Royal College of Psychiatrists: National Audit of Dementia Care in General Hospitals, Royal College of Psychiatrists’ Centre for Quality Improvement, Use of Antipsychotics for BPSD in UK Hospitals
Leave a comment
Antidepressants Not Recommended for Depression in People With Dementia (NIHR Signal / Cochrane Database)
Summary A National Institute for Health Research “Signal” expert commentary refers to a systematic review which indicates that antidepressants are unsuitable / unhelpful for the treatment of depression in persons living with dementia. Full Text Link Reference Antidepressants do not … Continue reading
Posted in Acute Hospitals, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, NIHR, Person-Centred Care, Pharmacological Treatments, Quick Insights, Systematic Reviews, UK, Universal Interest
Tagged Addenbrooke), Addenbrookes Hospital, Adverse Effects, Adverse Events, ALOIS: a Comprehensive Register of Dementia Studies, ALOIS: Cochrane Dementia and Cognitive Improvement's Specialized Register, ALOIS: the Cochrane Dementia and Cognitive Improvement Group, Antidepressants, Antidepressants for Agitation and Psychosis in Dementia, Antidepressants for Depression in Dementia, Antidepressants for Treating Depression in Dementia, Cambridge and Peterborough NHS Foundation Trust, Cambridge University Hospitals (Addenbrooke’s), Cochrane Database, Cochrane Database of Systematic Reviews, Cochrane Dementia and Cognitive Impairment Group, Cochrane UK, Department of Psychiatry: University of Cambridge, Drug Side-Effects, Inappropriate Medication, Inappropriate Prescribing, Later Life, Mental Health and Illness, National Institute for Health Research Signal, National Perinatal Epidemiology Unit (NPEU): University of Oxford, NIHR Signal, Older People’s Mental Health Service: Cambridge and Peterborough NHS Foundation Trust, Oxford Health NHS Foundation Trust, Potentially Inappropriate Medications (PIM), Potentially Inappropriate Prescribing, Potentially Inappropriate Prescribing (PIP), Potentially Inappropriate Prescribing in Depression and Dementia, Preventable Adverse Events, Professor Martin Orrell, Professor Martin Orrell: Director of Institute of Mental Health at University of Nottingham; Division of Psychiatry and Applied Psychology: University of Nottingham, Psychotropic Drug Use (Antipsychotics Antidepressants Hypnotics Anxiolytics Anticonvulsants Antidementia Drugs), Reducing Inappropriate Prescribing of Antidepressants, Selective Serotonin Reuptake Inhibitors (SSRIs), University of Cambridge, University of Nottingham, University of Oxford
Leave a comment
Management of BPSD in Alzheimer’s Disease (International Psychogeriatrics)
Summary A recent review examines current and emerging treatments for Behavioural and Psychological Symptoms of Dementia (BPSD) in Alzheimer’s Disease. This research was first aired at the 2015 International Psychogeriatric Association Meeting. The consensus view is that non-pharmacological approaches are … Continue reading
Posted in Acute Hospitals, Antipsychotics, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, UK
Tagged 2015 International Psychogeriatric Association Meeting, Agitation, Agitation and Aggression, Alternatives to Antipsychotic Drugs, Alternatives to Medication for Agitation, Antipsychotics in Elderly People with Dementia, Antipsychotics Limitation in Dementia, Behavioral and Psychological Symptoms of Dementia (BPSD), Behavioural Alternatives to Antipsychotic Drugs, Behavioural and Psychological Symptoms of Dementia (BPSD), BPSD in Alzheimer’s Disease, BPSD: Behavioral and Psychological Symptoms of Dementia, Consensus Statements About Dementia, Delphi Consensus, Department of Psychiatry and Behavioral Sciences: Johns Hopkins Bayview, Department of Psychiatry: University of Michigan, Describe Investigate Create and Evaluate (DICE) Approach, Dextromethorphan / Quinidine (DM/Q: Nuedexta™), Dextromethorphan Hydrobromide-Quinidine Sulfate, Dextromethorphan-Quinidine, Dextromethorphan-Quinidine for Agitation in Patients With Alzheimer’s Disease, Drugs for BPSD, Efficacy of Music Therapy, International Psychogeriatric Association Meeting (2015), International Psychogeriatrics, Interventions for BPSD, Johns Hopkins University, Management of BPSD in Alzheimer’s Disease, Managing Agitation, Medical School: University of Exeter, Music Therapy, Music Therapy and Dementia, Music Therapy for BPSD, Neuropsychiatric Symptoms (NPS), Neuropsychiatric Symptoms in People With Dementia, Pimavanserin, Potentially Inappropriate Medications (PIM), Potentially Inappropriate Prescribing (PIP), Potentially Inappropriate Prescribing in Advanced Dementia, Prescribing of Antipsychotic Drugs For People With Dementia, Program for Positive Aging, Reducing Agitation and Distress, Risperidone, United States, University of Exeter, University of Exeter Medical School, University of Michigan, USA
Leave a comment
Scoping the Potential Role(s) of Community Pharmacists in Medication Management for Community-Dwelling People With Dementia (Health Expectations)
Summary A new article has appeared on the roles for community pharmacists in assisting people with dementia dwelling in the community, their informal carers – and health and social care professionals more widely – in achieving safer and more effective … Continue reading
Posted in Antipsychotics, Commissioning, Community Care, Falls Prevention, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Local Interest, Management of Condition, Mental Health, Models of Dementia Care, National, NHS, NHS England, Person-Centred Care, Personalisation, Pharmacological Treatments, Quick Insights, Standards, UK, Universal Interest
Tagged Ability of Community Pharmacists to Limit Use of Antipsychotics Prescribed Inappropriately For BPSD, Aston Health Research and Innovation Cluster, Aston University, Birmingham (UK), Caregiving (Carers), Caring for Carers, Communication Between Community Pharmacists and Caregivers, Communication Between Community Pharmacists and GPs, Community Pharmacies, Community Pharmacists, Community Pharmacy, Community-Based Care, Community-Based Care for People With Dementia, Community-Based Interventions, Community-Based Services, Community-Based Support, Community-Centred Approaches, Community-Dwelling Older People with Dementia, Dementia Friendly Community Pharmacists, Dementia-Friendly Businesses, Dementia-Friendly Cities, Dementia-Friendly Communities, Dementia-Friendly Community Pharmacies, Dementia-Friendly Information, Dementia-Friendly Neighbourhoods, Dementia-Friendly Organisations, Dementia-Friendly Pharmacies, Healthy Lifestyles, Improving the Quality of Life for People with Long Term Conditions, Informal Carers, Information and Signposting Services, Integrated and Community-Based Care, Lifestyle Risk Factors, Long Term Conditions and Mental Health, Long-Term Conditions, Long-Term Conditions (LTCs), Long-Term Conditions and Dementia, MDTs: Multidisciplinary Teams, Medication Management, Medicines Adherence, Medicines Optimisation, Medicines Optimisation in Primary Care, Multidisciplinary Care, Multidisciplinary Team Care, Multidisciplinary Teamwork, Multiple Long-Term Conditions, NHS Community Pharmacy Contractual Framework (CPCF), NHS Community Pharmacy Contractual Framework (the Pharmacy Contract), Older Community-Dwelling Adults, Pharmacist-Led Home Medication Reviews, Pharmacy Quality Payments Scheme, Pharmacy: Aston University, Potentially Inappropriate Prescribing, Potentially Inappropriate Prescribing (PIP), Prevention, Prevention Agenda, Prevention of Avoidable Emergency Admissions: Proactive Management of Long-Term Conditions, Primary Care and Community Pharmacy Network, Proactive Management of Long-Term Conditions, Qualitative Exploratory Study, Qualitative Research, Qualitative Studies, Quality of Life for People With Long Term Conditions, Reducing Emergency Admissions Through Community-Based Interventions, School of Life and Health Sciences: Aston University, Self-Care, Self-Directed Support for Long Term Conditions, Self-Management, Self-Management Education, Self-Management in Chronic Illness, Self-Management in Early Stage Dementia, Self-Management of Long-Term Illnesses, Self-Management Support, Signposting, Signposting Patient Information, Signposting to Appropriate Health Services, Signposting to Sources of Practical Help, Support for Self-Care, Supporting Self-Care, University of East Anglia, University of Hull, Unmet Needs of Community-Dwelling Older Persons, Unpaid Carers
Leave a comment
